The North America Intermittent Catheter Market would witness market growth of 8.2% CAGR during the forecast period (2018 – 2024). Intermittent catheter is a type of urological catheter, and it is used in draining urine from the urinary bladder from individuals who have urological problems. These catheters are made from PVC or vinyl, latex rubber, and silicone materials. Intermittent catheters are majorly used by people with spinal cord injuries or people suffering from urinary incontinence. North America is the most lucrative market for intermittent catheter across the world. The growth in the region is due to the well- established healthcare infrastructure and rapid adoption of intermittent catheters in the healthcare ecosystem.
Based on Product, the market is segmented into Non-Coated Intermittent Catheter and Coated Intermittent Catheter. Based on Category, the market is segmented in Female Length Catheter, Male Length Catheter and Kids Length Catheter. Based on Indication, the market is segmented into Spinal Cord Injuries, Urinary Incontinence, General Surgery and Other Indication. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Medical Research Centers.. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson Company, B. Braun Melsungen AG, Coloplast Ltd., C. R. Bard, Inc., Hollister Incorporated, Medical Technologies of Georgia Inc., Teleflex Incorporated, Pennine Healthcare, Adapta Medical, ConvaTec Inc.
Our reports have been used by over 10K customers, including:
256 pages •
By Roots Analysis Private Ltd.
• Feb 2021
INTRODUCTION Over time, advances in molecular biology and pharmacological chemistry have enabled the identification of biological targets localized in the subcellular space, and development of therapeutic leads against them. In fact, there are several clinical conditions, which were previously considered undruggable since...
The North America Blood Purification Equipment Market would witness market growth of 4.3% CAGR during the forecast period (2020-2026). Rising cases of chronic kidney diseases (CKD) will bolster the growth of the market in the next few years. CKDS may result in chronic renal failure that requires a constant blood purification process....
Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By End Use (Healthcare Providers, Homecare), By Technology (Bluetooth, NFC), By Region, And Segment Forecasts, 2020 - 2027
Connected Drug Delivery Devices Market Growth & Trends
The global connected drug...
The North America liposome drug delivery market is expected to reach US$ 2735.64 million by 2027 from US$ 1390.53 million in 2019. The market is estimated to grow with a CAGR of 9% from 2020 to 2027. The liposome drug delivery market is growing primarily due to the Increasing Prevalence of chronic diseases, increasing demand for non-invasive...
The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
INTRODUCTION Over the years, advances in cell biology and pharmacology have led to the development of a variety of advanced biologics, which experts believe, possess the potential to address several unmet needs associated with the treatment of different types of diseases. Currently, there are more than 1,000 cell and gene...
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.